Global Genomics In Cancer Care Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
• 1.4 Market by Type
  • 1.4.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Instruments
  • 1.4.3 Consumables
  • 1.4.4 Services
• 1.5 Market by Application
  • 1.5.1 Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostics
  • 1.5.3 Personalized Medicine
  • 1.5.4 Drug Discovery
  • 1.5.5 Development
  • 1.5.6 Research
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Genomics In Cancer Care Market Perspective (2015-2026)
• 2.2 Global Genomics In Cancer Care Growth Trends by Regions
  • 2.2.1 Genomics In Cancer Care Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2015-2020)
  • 2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Genomics In Cancer Care Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Genomics In Cancer Care Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Genomics In Cancer Care Players by Market Size
  • 3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2015-2020)
  • 3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Genomics In Cancer Care Market Concentration Ratio
  • 3.2.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2019
• 3.3 Genomics In Cancer Care Key Players Head office and Area Served
• 3.4 Key Players Genomics In Cancer Care Product Solution and Service
• 3.5 Date of Enter into Genomics In Cancer Care Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Genomics In Cancer Care Historic Market Size by Type (2015-2020)
• 4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Genomics In Cancer Care Market Size by Application (2015-2020)
• 5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Genomics In Cancer Care Market Size (2015-2020)
• 6.2 Genomics In Cancer Care Key Players in North America (2019-2020)
• 6.3 North America Genomics In Cancer Care Market Size by Type (2015-2020)
• 6.4 North America Genomics In Cancer Care Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Genomics In Cancer Care Market Size (2015-2020)
• 7.2 Genomics In Cancer Care Key Players in Europe (2019-2020)
• 7.3 Europe Genomics In Cancer Care Market Size by Type (2015-2020)
• 7.4 Europe Genomics In Cancer Care Market Size by Application (2015-2020)

8 China

• 8.1 China Genomics In Cancer Care Market Size (2015-2020)
• 8.2 Genomics In Cancer Care Key Players in China (2019-2020)
• 8.3 China Genomics In Cancer Care Market Size by Type (2015-2020)
• 8.4 China Genomics In Cancer Care Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Genomics In Cancer Care Market Size (2015-2020)
• 9.2 Genomics In Cancer Care Key Players in Japan (2019-2020)
• 9.3 Japan Genomics In Cancer Care Market Size by Type (2015-2020)
• 9.4 Japan Genomics In Cancer Care Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Genomics In Cancer Care Market Size (2015-2020)
• 10.2 Genomics In Cancer Care Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020)
• 10.4 Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020)

11 India

• 11.1 India Genomics In Cancer Care Market Size (2015-2020)
• 11.2 Genomics In Cancer Care Key Players in India (2019-2020)
• 11.3 India Genomics In Cancer Care Market Size by Type (2015-2020)
• 11.4 India Genomics In Cancer Care Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Genomics In Cancer Care Market Size (2015-2020)
• 12.2 Genomics In Cancer Care Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Genomics In Cancer Care Market Size by Type (2015-2020)
• 12.4 Central & South America Genomics In Cancer Care Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina
  • 13.1.1 Illumina Company Details
  • 13.1.2 Illumina Business Overview
  • 13.1.3 Illumina Genomics In Cancer Care Introduction
  • 13.1.4 Illumina Revenue in Genomics In Cancer Care Business (2015-2020))
  • 13.1.5 Illumina Recent Development
• 13.2 Thermo Fisher scientific
  • 13.2.1 Thermo Fisher scientific Company Details
  • 13.2.2 Thermo Fisher scientific Business Overview
  • 13.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
  • 13.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.2.5 Thermo Fisher scientific Recent Development
• 13.3 Agilent
  • 13.3.1 Agilent Company Details
  • 13.3.2 Agilent Business Overview
  • 13.3.3 Agilent Genomics In Cancer Care Introduction
  • 13.3.4 Agilent Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.3.5 Agilent Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview
  • 13.4.3 Roche Genomics In Cancer Care Introduction
  • 13.4.4 Roche Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 Cancer Genetics
  • 13.5.1 Cancer Genetics Company Details
  • 13.5.2 Cancer Genetics Business Overview
  • 13.5.3 Cancer Genetics Genomics In Cancer Care Introduction
  • 13.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.5.5 Cancer Genetics Recent Development
• 13.6 Beckman Coulter
  • 13.6.1 Beckman Coulter Company Details
  • 13.6.2 Beckman Coulter Business Overview
  • 13.6.3 Beckman Coulter Genomics In Cancer Care Introduction
  • 13.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.6.5 Beckman Coulter Recent Development
• 13.7 Bio-Rad
  • 13.7.1 Bio-Rad Company Details
  • 13.7.2 Bio-Rad Business Overview
  • 13.7.3 Bio-Rad Genomics In Cancer Care Introduction
  • 13.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.7.5 Bio-Rad Recent Development
• 13.8 Danaher
  • 13.8.1 Danaher Company Details
  • 13.8.2 Danaher Business Overview
  • 13.8.3 Danaher Genomics In Cancer Care Introduction
  • 13.8.4 Danaher Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.8.5 Danaher Recent Development
• 13.9 Sigma Aldrich
  • 13.9.1 Sigma Aldrich Company Details
  • 13.9.2 Sigma Aldrich Business Overview
  • 13.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
  • 13.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.9.5 Sigma Aldrich Recent Development
• 13.10 Pacific Biosciences
  • 13.10.1 Pacific Biosciences Company Details
  • 13.10.2 Pacific Biosciences Business Overview
  • 13.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
  • 13.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020)
  • 13.10.5 Pacific Biosciences Recent Development
• 13.11 Quest Diagnostics
  • 10.11.1 Quest Diagnostics Company Details
  • 10.11.2 Quest Diagnostics Business Overview
  • 10.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
  • 10.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.11.5 Quest Diagnostics Recent Development
• 13.12 Luminex
  • 10.12.1 Luminex Company Details
  • 10.12.2 Luminex Business Overview
  • 10.12.3 Luminex Genomics In Cancer Care Introduction
  • 10.12.4 Luminex Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.12.5 Luminex Recent Development
• 13.13 Oxford Gene Technology
  • 10.13.1 Oxford Gene Technology Company Details
  • 10.13.2 Oxford Gene Technology Business Overview
  • 10.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
  • 10.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.13.5 Oxford Gene Technology Recent Development
• 13.14 PerkinElmer
  • 10.14.1 PerkinElmer Company Details
  • 10.14.2 PerkinElmer Business Overview
  • 10.14.3 PerkinElmer Genomics In Cancer Care Introduction
  • 10.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.14.5 PerkinElmer Recent Development
• 13.15 Qiagen
  • 10.15.1 Qiagen Company Details
  • 10.15.2 Qiagen Business Overview
  • 10.15.3 Qiagen Genomics In Cancer Care Introduction
  • 10.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.15.5 Qiagen Recent Development
• 13.16 GE Healthcare
  • 10.16.1 GE Healthcare Company Details
  • 10.16.2 GE Healthcare Business Overview
  • 10.16.3 GE Healthcare Genomics In Cancer Care Introduction
  • 10.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.16.5 GE Healthcare Recent Development
• 13.17 Thermo Fisher scientific
  • 10.17.1 Thermo Fisher scientific Company Details
  • 10.17.2 Thermo Fisher scientific Business Overview
  • 10.17.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
  • 10.17.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
  • 10.17.5 Thermo Fisher scientific Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer